These proliferative effects arise through both mechanotransduction, whereby matrix stiffness and strain activate intracellular sensors such as YAP/TAZ, and ligand–receptor signaling, including laminin-Notch and hyaluronan-CD44 interactions, highlighting multiple, non-redundant routes by which the ECM reinforces tumor growth. The gene discussed is LAMB2; the disease is neoplasm.